Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ClinTec International, a global CRO with a presence in over 40 countries worldwide, welcomed Glasgow’s Lord Provost Sadie Docherty to its UK Headquarters in Glasgow on Tuesday to mark the formal launch of the company’s MSc in International Clinical ...
read more
Wednesday, February 15, 2017
Clintec has announced the launch of its new brand identity - reflected in their newly created website. This in part marks Clintec’s 20th anniversary and the achievement of significant milestones following another year of substantial growth, together ...
read more
Wednesday, January 13, 2016
ClinTec International has announced the appointment of Dr. Harley Simon, MD, as Chief Medical Officer (CMO) and Executive Vice President (EVP) Client Relations. Dr. Simon is a physician registered in the UK and South Africa with almost 20 years of ...
read more
WIRB-Copernicus Group® a provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that Clintrax Global has joined its family of companies.
read more
Thursday, December 18, 2025
ClinTrial Research (CTR) announced that it has closed a growth equity round led by Tarsadia Investments, a multi-billion-dollar firm that makes high-conviction investments in category-defining companies globally. The investment reflects Tarsadia's ...
read more
Cloud Pharmaceuticals have entered into drug discovery collaboration with GlaxoSmithKline.
read more
Monday, November 02, 2015
CluePoints today announced a strategic collaboration with clinical trials business solutions consultancy, Widler & Schiemann Ltd. The collaboration will bring together CluePoints' award-winning RBM software with Widler & Schiemann's risk-assessment ...
read more
CluePoints has entered into an enterprise agreement with Japanese drug development organization, ONO Pharmaceutical.
read more
CluePoints announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.
read more
Tuesday, October 02, 2018
CluePoints has announced the appointment of two industry thought-leaders to its senior team.
read more
Friday, December 16, 2022
CluePoints, announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche, who is stepping back as CEO to focus his full attention on the strategic direction of CluePoints’ world-leading ...
read more
CluePoints announced Usama Dar as its new Chief Product and Technology Officer. Having led both product and R&D teams through significant expansion, Usama is ideally placed to help CluePoints in the next phase of its growth journey.
read more
Thursday, January 15, 2026
CluePoints has appointed Sinead Godkin as its new Chief People Officer (CPO). With deep experience scaling global technology organizations through periods of rapid growth, Godkin will lead CluePoints’ people strategy as the company enters its next ...
read more
CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has appointed Steve Young as Senior Vice President of its US Operations. The appointment marks a key strategic move for the company in ...
read more
Wednesday, March 18, 2020
CluePoints has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.
read more